Reimagining Anticoagulation Clinics in the Era of Direct Oral Anticoagulants

作者: Geoffrey D. Barnes , Brahmajee K. Nallamothu , Anne E. Sales , James B. Froehlich

DOI: 10.1161/CIRCOUTCOMES.115.002366

关键词:

摘要: Anticoagulation clinics were initially developed to provide safe and effective care for warfarin-treated patients with atrial fibrillation, venous thromboembolism, mechanical valve replacement. Traditionally, these required ongoing laboratory monitoring warfarin dose adjustment by expert providers. With the introduction of direct oral anticoagulants (dabigatran, rivaroxaban, apixaban, edoxaban), many have questioned need anticoagulation clinic. However, we think that growing number anticoagulant choices creates an urgent expanding traditional role We outline 3 key purposes a reimagined clinic would serve: (1) assist clinicians selecting most appropriate drug from list options (including warfarin), (2) help minimize risk serious bleeding complications careful long-term peri-procedural management, (3) encourage adherence life-saving medications. also describe how repurposing as broader medication safety promote across range cardiovascular conditions high-risk medications (eg, spironolactone, amiodarone). Finally, highlight few existing health systems are overcoming challenges implementing or structure.

参考文章(15)
Geoffrey D. Barnes, Eleanor Lucas, G. Caleb Alexander, Zachary D. Goldberger, National Trends in Ambulatory Oral Anticoagulant Use The American Journal of Medicine. ,vol. 128, pp. 1300- 1305.e2 ,(2015) , 10.1016/J.AMJMED.2015.05.044
Brian M. Salata, David W. Hutton, Deborah A. Levine, James B. Froehlich, Geoffrey D. Barnes, Cost-Effectiveness of Dabigatran (150 mg Twice Daily) and Warfarin in Patients ≥ 65 Years With Nonvalvular Atrial Fibrillation. American Journal of Cardiology. ,vol. 117, pp. 54- 60 ,(2016) , 10.1016/J.AMJCARD.2015.09.048
Douketis JD, Spyropoulos AC, et al, None, Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation The New England Journal of Medicine. ,vol. 373, pp. 823- 833 ,(2015) , 10.1056/NEJMOA1501035
Supriya Shore, P. Michael Ho, Anne Lambert-Kerzner, Thomas J. Glorioso, Evan P. Carey, Fran Cunningham, Lisa Longo, Cynthia Jackevicius, Adam Rose, Mintu P. Turakhia, Site-level variation in and practices associated with dabigatran adherence. JAMA. ,vol. 313, pp. 1443- 1450 ,(2015) , 10.1001/JAMA.2015.2761
G. D. Barnes, W. Ageno, J. Ansell, S. Kaatz, Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH Journal of Thrombosis and Haemostasis. ,vol. 13, pp. 2132- 2133 ,(2015) , 10.1111/JTH.13136
Benjamin A. Steinberg, Eric D. Peterson, Sunghee Kim, Laine Thomas, Bernard J. Gersh, Gregg C. Fonarow, Peter R. Kowey, Kenneth W. Mahaffey, Matthew W. Sherwood, Paul Chang, Jonathan P. Piccini, Jack Ansell, Use and Outcomes Associated with Bridging During Anticoagulation Interruptions in Patients with Atrial Fibrillation: Findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Circulation. ,vol. 131, pp. 488- 494 ,(2015) , 10.1161/CIRCULATIONAHA.114.011777
Vanessa Roldán, Francisco Marín, Hermógenes Fernández, Sergio Manzano-Fernández, Pilar Gallego, Mariano Valdés, Vicente Vicente, Gregory Y.H. Lip, Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding). American Journal of Cardiology. ,vol. 111, pp. 1159- 1164 ,(2013) , 10.1016/J.AMJCARD.2012.12.045
Michele M. Spence, Jennifer K. Polzin, Calvin L. Weisberger, John P. Martin, Jay P. Rho, Giselle H. Willick, Evaluation of a Pharmacist-Managed Amiodarone Monitoring Program Journal of Managed Care Pharmacy. ,vol. 17, pp. 513- 522 ,(2011) , 10.18553/JMCP.2011.17.7.513
Dariush Mozaffarian, Emelia J Benjamin, Alan S Go, Donna K Arnett, Michael J Blaha, Mary Cushman, Sarah De Ferranti, Jean-Pierre Després, Heather J Fullerton, Virginia J Howard, Mark D Huffman, Suzanne E Judd, Brett M Kissela, Daniel T Lackland, Judith H Lichtman, Lynda D Lisabeth, Simin Liu, Rachel H Mackey, David B Matchar, Darren K McGuire, Emile R Mohler III, Claudia S Moy, Paul Muntner, Michael E Mussolino, Khurram Nasir, Robert W Neumar, Graham Nichol, Latha Palaniappan, Dilip K Pandey, Mathew J Reeves, Carlos J Rodriguez, Paul D Sorlie, Joel Stein, Amytis Towfighi, Tanya N Turan, Salim S Virani, Joshua Z Willey, Daniel Woo, Robert W Yeh, Melanie B Turner, None, Heart disease and stroke statistics-2015 update: A report from the American Heart Association Circulation. ,vol. 131, ,(2015) , 10.1161/CIR.0000000000000152